Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study

Carlo Visco, Ken H. Young, Michael Møller et al.|Haematologica|2012

Cited by 165